Sign In
Buy TRCK
$0.640
+0 (+0%)
At Close: Jun 03, 2026
Ross Stores on Track With Store Expansions, Inaugurates 47 Locations
02:00pm, Tuesday, 22'nd Oct 2024
ROST's strategic efforts, including store expansion plans and business model, appear encouraging.
Bitcoin on Track to Hit $70,000: 4 Crypto-Centric Stocks With Upside
09:31am, Monday, 21'st Oct 2024
Bitcoin-centric stocks like NVDA, CME, IBKR and ACN are poised to gain from the ongoing cryptocurrency rally.
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today
VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the "Company" or "Calibre") announces operating results for the three months (“Q3”) an
Wesdome Announces Q3 2024 Production; on Track for Record Production Year
06:30am, Thursday, 17'th Oct 2024
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) today announces its production results for the third quarter ended Sept
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
11:45am, Wednesday, 16'th Oct 2024
Saint Herblain (France) and Schlieren (Zurich), October 16, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech c
Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
09:07am, Tuesday, 15'th Oct 2024
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology
American Eagle Outfitters: Back On Track For Growth
02:41am, Tuesday, 15'th Oct 2024
American Eagle Outfitters shows promising growth, with a notable turnaround in its American Eagle brand, achieving four consecutive quarters of sales growth. Despite lowering growth guidance, AEO exce
Nvidia Roars Back, on Track For Record High
02:18pm, Monday, 14'th Oct 2024
Nvidia's shares are roaring back after the company successfully calmed investor concerns about product delays and its long-term growth prospects. Bloomberg's Ryan Vlastelica joins Caroline Hyde and Ed
FEMSA to Divest Some Operations in Mexico, On Track With Forward Plan
01:36pm, Monday, 14'th Oct 2024
FMX looks forward to divesting its few logistic operations to Grupo Traxion.
ROAD TOWN, British Virgin Islands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) announces Q3 2024 preliminary producti
Thesis Gold Announces Completion of 2024 Field Program: On Track to Commence PFS and EIA in Early 2025
06:30am, Monday, 07'th Oct 2024
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2024) - Thesis Gold Inc. (TSXV: TAU) (WKN: A3EP87) (OTCQX: THSGF) ("Thesis" or the "Company") is pleased to announce the successful completio
Track And Trace, But Don't Race: Why ReposiTrak Might Be Overvalued
04:29am, Sunday, 06'th Oct 2024
ReposiTrak shows solid growth potential with traceability services and recurring revenue but is currently overvalued with a high P/E ratio of 62.09x. Despite strong financials and profitability, risin
Summit Therapeutics Stock Jumps as Lung Cancer Drug Placed on FDA Fast Track
10:35am, Friday, 04'th Oct 2024
Summit Therapeutics (SMMT) shares surged Friday morning, a day after after the biopharmaceutical company said its developmental lung cancer drug was granted Fast Track designation by the Food and Drug
Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
07:00am, Tuesday, 01'st Oct 2024
Zilganersen is the first investigational medicine in clinical development for adults and children living with Alexander disease, an ultra-rare neurological condition CARLSBAD, Calif. , Oct. 1, 2024 /P
